Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anda Gershon

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Psychiatric Research|April 29, 2011
Life stress and first onset of psychiatric disorders in daughters of depressed mothersAnda Gershon, Chris Hayward, Pamela Schraedley-Desmond, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|November 14, 2015
Individuals with Autism Spectrum Disorders Have Equal Success Rate But Require Longer Periods of Systematic Desensitization than Control Patients to Complete Ambulatory PolysomnographyMichelle Primeau, Anda Gershon, Lisa Talbot, et al.
Journal of Clinical Psychopharmacology|April 6, 2018
Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar DisorderShefali Miller, Dennis Do, Anda Gershon, et al.
Journal of Affective Disorders|August 28, 2017
Subjective versus objective evening chronotypes in bipolar disorderAnda Gershon, Christopher N Kaufmann, Colin A Depp, et al.
Journal of Affective Disorders|May 14, 2017
Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorderAnda Gershon, Dennis Do, Satyanand Satyanarayana, et al.
Journal of Affective Disorders|February 24, 2019
Antidepressants have complex associations with longitudinal depressive burden in bipolar disorderFarnaz Hooshmand, Dennis Do, Saloni Shah, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community SettingAnda Gershon, Esprit Ma, Tao Xu, et al.
Journal of Affective Disorders|March 11, 2018
Differential prevalence and demographic and clinical correlates of antidepressant use in American bipolar I versus bipolar II disorder patientsFarnaz Hooshmand, Dennis Do, Saloni Shah, et al.
Cancer Reports (Hoboken, N.J.)|January 25, 2022
Real-world data prognostic model of overall survival in patients with advanced NSCLC receiving anti-PD-1/PD-L1 immune checkpoint inhibitors as second-line monotherapyCristina Julian, Robson J M Machado, Sandhya Girish, et al.
The Oncologist|August 4, 2022
Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the USPankit Vachhani, Evelyn M Flahavan, Tao Xu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Psychiatric Research|April 29, 2011
Life stress and first onset of psychiatric disorders in daughters of depressed mothersAnda Gershon, Chris Hayward, Pamela Schraedley-Desmond, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|November 14, 2015
Individuals with Autism Spectrum Disorders Have Equal Success Rate But Require Longer Periods of Systematic Desensitization than Control Patients to Complete Ambulatory PolysomnographyMichelle Primeau, Anda Gershon, Lisa Talbot, et al.
Journal of Clinical Psychopharmacology|April 6, 2018
Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar DisorderShefali Miller, Dennis Do, Anda Gershon, et al.
Journal of Affective Disorders|August 28, 2017
Subjective versus objective evening chronotypes in bipolar disorderAnda Gershon, Christopher N Kaufmann, Colin A Depp, et al.
Journal of Affective Disorders|May 14, 2017
Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorderAnda Gershon, Dennis Do, Satyanand Satyanarayana, et al.
Journal of Affective Disorders|February 24, 2019
Antidepressants have complex associations with longitudinal depressive burden in bipolar disorderFarnaz Hooshmand, Dennis Do, Saloni Shah, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community SettingAnda Gershon, Esprit Ma, Tao Xu, et al.
Journal of Affective Disorders|March 11, 2018
Differential prevalence and demographic and clinical correlates of antidepressant use in American bipolar I versus bipolar II disorder patientsFarnaz Hooshmand, Dennis Do, Saloni Shah, et al.
Cancer Reports (Hoboken, N.J.)|January 25, 2022
Real-world data prognostic model of overall survival in patients with advanced NSCLC receiving anti-PD-1/PD-L1 immune checkpoint inhibitors as second-line monotherapyCristina Julian, Robson J M Machado, Sandhya Girish, et al.
The Oncologist|August 4, 2022
Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the USPankit Vachhani, Evelyn M Flahavan, Tao Xu, et al.
Pageof 4